Venous Thromboembolism Summary

2847 relevant articles (201 outcomes, 544 trials/studies) found for this Disease

Key Drugs and Agents for Venous Thromboembolism

1. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight) : 79 outcomes 109 studies in 419 results : IBA
   
2. Heparin (Liquaemin) : 51 outcomes 69 studies in 385 results : FDA 69 Generic
   
3. Warfarin (Coumadin) : 25 outcomes 44 studies in 193 results : FDA 20 Generic
   
4. Enoxaparin (Lovenox) : 23 outcomes 56 studies in 161 results : FDA 2
   
5. fondaparinux (Arixtra) : 18 outcomes 33 studies in 113 results : FDA 1
   
6. Thrombin : 12 outcomes 18 studies in 84 results : IBA
   
7. ximelagatran (Exanta) : 11 outcomes 35 studies in 81 results : IBA
   
8. Anticoagulants : 9 outcomes 14 studies in 139 results : IBA
   
9. Vitamin K : 6 outcomes 14 studies in 49 results : FDA 6
   
10. Dalteparin (Dalteparin Sodium) : 5 outcomes 17 studies in 48 results : FDA 2
    

Diseases Related to Venous Thromboembolism

1. Hemorrhage
2. Venous Thrombosis (Deep-Vein Thrombosis)
3. Neoplasms (Cancer)
4. Myocardial Infarction
5. Atrial Fibrillation

Key Therapies for Venous Thromboembolism

1. Arthroplasty : 6 outcomes 17 studies in 74 results
   
2. Hip Replacement Arthroplasty (Total Hip Replacement) : 4 outcomes 15 studies in 47 results
   
3. Knee Replacement Arthroplasty (Total Knee Replacement) : 4 outcomes 13 studies in 37 results
   
4. Compression Stockings : 4 outcomes 3 studies in 28 results
   
5. Vena Cava Filters (Inferior Vena Cava Filter) : 2 outcomes 4 studies in 30 results